June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

February 5, 2015February 5, 2015

Prognostic Differences Between Male and Female Melanoma Patients

News

In a recent study titled “Prognostic differences across sexes in melanoma patients: what has changed from the past?”, published in Melanoma Research, a research team from the University of Turin ... Read more

February 4, 2015February 4, 2015

Researchers Analyze BRAF V600 Mutations In Japanese Melanoma Patients

News

In a recent study titled “BRAF V600 mutations and pathological features in Japanese melanoma patients”, published in Melanoma Research, a research team from the National Cancer Center Hospital, Tokyo, has ... Read more

February 3, 2015February 3, 2015

Study Evaluates The Risk of Secondary Cancer After Non-Melanoma Skin Cancer

News

A team of researchers from the Geisel School of Medicine at Dartmouth, have examined the individual risk factors correlated with the development of subsequent cancers after non-melanoma skin cancer. The study, ... Read more

February 2, 2015February 2, 2015

Ipilimumab Efficient in Kidney Transplantation Patients With Metastatic Melanoma

News

In a study titled “Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma”, a team of researchers from Johns Hopkins University School of Medicine and Sidney Kimmel ... Read more

January 30, 2015January 30, 2015

Antibiotics Efficiently Kill Skin Cancer Stem Cells

News

A group of researchers led by Professor Michael P. Lisanti, Director of the Breakthrough Breast Cancer Unit, have published results of a recent study in Oncotarget, whereby they demonstrate the promising ... Read more

January 29, 2015January 29, 2015

Provectus’ New Synthesis Patent Application For Rose Bengal Allowed By Chinese Office

News

Provectus Biopharmaceuticals, Inc. has announced the approval from the Chinese Patent Office for its patent application protecting the synthetic process used to produce Rose Bengal, the active ingredient in PV-10, the ... Read more

January 28, 2015January 28, 2015

New Research Finds Cells Responsible For Merkel Cell Carcinoma Development

News

In a recent study titled “Unipotent, Atoh1+ progenitors maintain the Merkel cell population in embryonic and adult mice”, published in the The Journal of Cell Biology, a team of researchers has identified ... Read more

January 27, 2015January 27, 2015

Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma

News

In a recent study titled “Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study”, published in the PlosOne journal, a research team from ... Read more

January 26, 2015January 26, 2015

Study Uncovers Key Factor In Melanoma Metastases Formation

News

Rapid and progressive melanoma development is most often attributed to genetic mutations. However, a recent study by University of Zurich researchers has found that epigenetic factors play a key role in ... Read more

January 23, 2015January 23, 2015

Genetic Analysis Reveals Melanoma Drivers

News

University of California researchers have mapped the genetic composition of melanoma, identifying crucial mutational hotspots responsible for cancer development. In the study “Cancer systems biology of TCGA SKCM: Efficient detection ... Read more

January 22, 2015January 22, 2015

Coffee Associated With a Lower Risk of Malignant Melanoma, According to Study

News

Coffee consumption may be associated with a lower risk of malignant melanoma, according to a recent study published in the Journal of the National Cancer Institute. Cutaneous melanoma is the ... Read more

January 21, 2015January 21, 2015

Researchers Find Link Between Aggressive Acne And Melanoma Risk

News

In a recent study titled “Teenage Acne and Cancer Risk in US Women: A Prospective Cohort Study”, published in the Cancer Journal, a team of researchers from Harvard Medical School ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group